204 related articles for article (PubMed ID: 1457333)
1. Nephrogenic diabetes insipidus: clinical symptoms, pathogenesis, genetics and treatment.
Knoers N; Monnens LA
Pediatr Nephrol; 1992 Sep; 6(5):476-82. PubMed ID: 1457333
[TBL] [Abstract][Full Text] [Related]
2. Nephrogenic diabetes insipidus: identification of the genetic defect.
Knoers N; van den Ouweland A; Dreesen J; Verdijk M; Monnens LA; van Oost BA
Pediatr Nephrol; 1993 Oct; 7(5):685-8. PubMed ID: 8251344
[TBL] [Abstract][Full Text] [Related]
3. Successful treatment with hydrochlorothiazide and amiloride in an infant with congenital nephrogenic diabetes insipidus.
Uyeki TM; Barry FL; Rosenthal SM; Mathias RS
Pediatr Nephrol; 1993 Oct; 7(5):554-6. PubMed ID: 8251321
[TBL] [Abstract][Full Text] [Related]
4. Derivatives of somatic cell hybrids which carry the human gene locus for nephrogenic diabetes insipidus (NDI) express functional vasopressin renal V2-type receptors.
Jans DA; van Oost BA; Ropers HH; Fahrenholz F
J Biol Chem; 1990 Sep; 265(26):15379-82. PubMed ID: 2168411
[TBL] [Abstract][Full Text] [Related]
5. Hydrochlorothiazide-amiloride in the treatment of congenital nephrogenic diabetes insipidus.
Alon U; Chan JC
Am J Nephrol; 1985; 5(1):9-13. PubMed ID: 3970081
[TBL] [Abstract][Full Text] [Related]
6. Nephrogenic diabetes insipidus. Radiological and clinical features.
Hartenberg MA; Cory M; Chan JC
Int J Pediatr Nephrol; 1985; 6(4):281-6. PubMed ID: 4093246
[TBL] [Abstract][Full Text] [Related]
7. Amiloride-hydrochlorothiazide versus indomethacin-hydrochlorothiazide in the treatment of nephrogenic diabetes insipidus.
Knoers N; Monnens LA
J Pediatr; 1990 Sep; 117(3):499-502. PubMed ID: 2391611
[No Abstract] [Full Text] [Related]
8. V2R mutations and nephrogenic diabetes insipidus.
Bichet DG
Prog Mol Biol Transl Sci; 2009; 89():15-29. PubMed ID: 20374732
[TBL] [Abstract][Full Text] [Related]
9. X-linked nephrogenic diabetes insipidus: from the ship Hopewell to RFLP studies.
Bichet DG; Hendy GN; Lonergan M; Arthus MF; Ligier S; Pausova Z; Kluge R; Zingg H; Saenger P; Oppenheimer E
Am J Hum Genet; 1992 Nov; 51(5):1089-1102. PubMed ID: 1357965
[TBL] [Abstract][Full Text] [Related]
10. Two novel mutations in the vasopressin V2 receptor gene in unrelated Japanese kindreds with nephrogenic diabetes insipidus.
Tsukaguchi H; Matsubara H; Aritaki S; Kimura T; Abe S; Inada M
Biochem Biophys Res Commun; 1993 Dec; 197(2):1000-10. PubMed ID: 8267567
[TBL] [Abstract][Full Text] [Related]
11. Treatment of nephrogenic diabetes insipidus with hydrochlorothiazide and amiloride.
Kirchlechner V; Koller DY; Seidl R; Waldhauser F
Arch Dis Child; 1999 Jun; 80(6):548-52. PubMed ID: 10332005
[TBL] [Abstract][Full Text] [Related]
12. A variant of nephrogenic diabetes insipidus: V2 receptor abnormality restricted to the kidney.
Knoers N; Monnens LA
Eur J Pediatr; 1991 Mar; 150(5):370-3. PubMed ID: 1828422
[TBL] [Abstract][Full Text] [Related]
13. Localization of the gene for X-linked nephrogenic diabetes insipidus to Xq28.
Kambouris M; Dlouhy SR; Trofatter JA; Conneally PM; Hodes ME
Am J Med Genet; 1988 Jan; 29(1):239-46. PubMed ID: 2894172
[TBL] [Abstract][Full Text] [Related]
14. Mutations in the V2 vasopressin receptor gene are associated with X-linked nephrogenic diabetes insipidus.
Pan Y; Metzenberg A; Das S; Jing B; Gitschier J
Nat Genet; 1992 Oct; 2(2):103-6. PubMed ID: 1303257
[TBL] [Abstract][Full Text] [Related]
15. Autosomal recessive inheritance of vasopressin-resistant diabetes insipidus.
Langley JM; Balfe JW; Selander T; Ray PN; Clarke JT
Am J Med Genet; 1991 Jan; 38(1):90-4. PubMed ID: 1672792
[TBL] [Abstract][Full Text] [Related]
16. Three-point linkage analysis using multiple DNA polymorphic markers in families with X-linked nephrogenic diabetes insipidus.
Knoers N; van der Heyden H; van Oost BA; Monnens L; Willems J; Ropers HH
Genomics; 1989 Apr; 4(3):434-7. PubMed ID: 2714800
[TBL] [Abstract][Full Text] [Related]
17. Nephrogenic diabetes insipidus in children (Review).
Duicu C; Pitea AM; Săsăran OM; Cozea I; Man L; Bănescu C
Exp Ther Med; 2021 Jul; 22(1):746. PubMed ID: 34055061
[TBL] [Abstract][Full Text] [Related]
18. Colocalization of the gene for nephrogenic diabetes insipidus (DIR) and the vasopressin type 2 receptor gene (AVPR2) in the Xq28 region.
van den Ouweland AM; Knoop MT; Knoers VV; Markslag PW; Rocchi M; Warren ST; Ropers HH; Fahrenholz F; Monnens LA; van Oost BA
Genomics; 1992 Aug; 13(4):1350-2. PubMed ID: 1324225
[TBL] [Abstract][Full Text] [Related]
19. Proposed cause of marked vasopressin resistance in a female with an X-linked recessive V2 receptor abnormality.
Moses AM; Sangani G; Miller JL
J Clin Endocrinol Metab; 1995 Apr; 80(4):1184-6. PubMed ID: 7714087
[TBL] [Abstract][Full Text] [Related]
20. [Long-term course of 6 boys with congenital nephrogenic diabetes insipidus].
Kaulitz R; Brodehl J
Klin Padiatr; 1989; 201(6):425-30. PubMed ID: 2601280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
